CM
MRTX

Caption Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Caption Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-36,600
Closed -$2.15M – 1787
2023
Q4 		$2.15M Sell
36,600
-14,400
-28% -$810K 0.03% 596
2023
Q3 		$2.22M Buy
51,000
+2,000
+4% +$71.4K 0.03% 552
2023
Q2 		$1.77M Buy
+49,000
New +$2.02M 0.03% 527
2023
Q1 		– Sell
-147,900
Closed -$6.7M – 1684
2022
Q4 		$6.7M Buy
147,900
+73,661
+99% +$4.77M 0.1% 242
2022
Q3 		$5.18M Buy
+74,239
New +$5.49M 0.07% 335
2022
Q2 		– Sell
-11,000
Closed -$700K – 1948
2022
Q1 		$904K Buy
11,000
+604
+6% +$61.8K 0.01% 1013
2021
Q4 		$1.52M Sell
10,396
-75,515
-88% -$11.7M 0.02% 885
2021
Q3 		$15.2M Buy
85,911
+68,911
+405% +$11.1M 0.17% 147
2021
Q2 		$2.75M Sell
17,000
-15,900
-48% -$2.55M 0.04% 566
2021
Q1 		$5.64M Buy
32,900
+25,875
+368% +$5.12M 0.12% 221
2020
Q4 		$1.54M Buy
7,025
+1,585
+29% +$343K 0.04% 505
2020
Q3 		$903K Buy
+5,440
New +$744K 0.02% 642
2020
Q1 		– Sell
-24,300
Closed -$2.18M – 1143
2019
Q4 		$3.13M Buy
+24,300
New +$2.34M 0.11% 265
2019
Q2 		– Sell
-40,000
Closed -$3.11M – 868
2019
Q1 		$2.93M Buy
+40,000
New +$2.72M 0.16% 182

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Caption Management's MRTX Position: Q1 2024 in Review

Caption Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 36,600 shares — an estimated $2.15M sold.

Caption Management first reported a position in MRTX in Q1 2019 and held it in 14 quarters. The position peaked at $15.2M in Q3 2021. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Caption Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Caption Management sold 36,600 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $2.15M.
  • Caption Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2019 and held it in 14 quarters.
  • Caption Management's Mirati Therapeutics, Inc. Common Stock position peaked at $15.2M in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Caption Management's 13F filing for Q1 2024, filed 15 May 2024.